Free Malaysia Today on MSN
Pfizer, Tris Pharma settle for US$41.5mil in Texas ADHD drug case
The settlement ends a 2023 lawsuit alleging pharmaceutical companies manipulated ADHD medication quality tests.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback